Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFpEF) is an unsolved and growing concern in cardiovascular medicine. While no treatment options that improve prognosis in HFpEF patients has been established so far, SGLT2 inhibitors (SGLT2i) are currently being investigated for the treatment of HFpEF...

Descripción completa

Detalles Bibliográficos
Autores principales: Pabel, Steffen, Hamdani, Nazha, Singh, Jagdeep, Sossalla, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602188/
https://www.ncbi.nlm.nih.gov/pubmed/34803735
http://dx.doi.org/10.3389/fphys.2021.752370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602188/
https://www.ncbi.nlm.nih.gov/pubmed/34803735
http://dx.doi.org/10.3389/fphys.2021.752370

Ejemplares similares